Cardlytics stock surges 73.4% on American Express news and Citron Research's bullish tweet.

Thursday, Sep 18, 2025 1:10 pm ET1min read

Cardlytics (CDLX) shares surge 73.4% to $2.48 as investors link the company's business model to American Express' updated Platinum card, which focuses on first-party data. Citron Research tweeted that CDLX is the "next fallen angel to trade much higher." The stock's explosive move suggests investors believe Cardlytics' platform will drive higher demand across the financial industry.

Cardlytics (CDLX) shares surged 73.4% to $2.48 on Monday, September 12, 2025, following a positive mention from Citron Research and the recent update to American Express' Platinum card. The stock's explosive move suggests investors believe Cardlytics' platform will drive higher demand across the financial industry.

Citron Research described Cardlytics as the "next fallen angel to trade much higher," highlighting the company's integration with major financial institutions such as American Express, Chase, Bank of America, Wells Fargo, Citibank, and Lloyds. The research firm specifically pointed to American Express’s recent Platinum card refresh as evidence supporting their bullish view on Cardlytics Cardlytics stock soars after positive mention from Citron Research[1].

The update to American Express' Platinum card, which includes a $200 increase in its annual fee to $895 and new benefits such as $400 in annual dining credits at Resy restaurants, $300 for Lululemon Athletica purchases, and $200 toward Oura rings, is seen as a potential catalyst for Cardlytics. The company operates a platform that enables banks to run rewards programs and provides marketers with insights based on purchase data, positioning it to benefit from the increasing value banks place on customer data and loyalty programs Cardlytics stock soars after positive mention from Citron Research[1].

Cardlytics' stock has seen significant volatility in recent years, with price targets ranging from $35 to $150, reflecting the market's perception of the company's growth potential and challenges U.S.: Nasdaq[2]. The latest surge in the stock price suggests that investors are now more optimistic about Cardlytics' ability to capitalize on the growing demand for first-party data and loyalty programs.

As Cardlytics continues to integrate with major financial institutions and develop its platform, it will be important for investors to monitor the company's earnings reports and analyst ratings to gauge its progress and potential for future growth.

Cardlytics stock surges 73.4% on American Express news and Citron Research's bullish tweet.

Comments



Add a public comment...
No comments

No comments yet